<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03850925</url>
  </required_header>
  <id_info>
    <org_study_id>2019_02_004</org_study_id>
    <nct_id>NCT03850925</nct_id>
  </id_info>
  <brief_title>Comparison of Picosecond Pulsed Nd:YAG Laser and Fractional Laser for the Treatment of Acne Scars</brief_title>
  <official_title>Comparison of Picosecond Pulsed Nd:YAG Laser and Fractional Laser for the Treatment of Acne Scars</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dongtan Sacred Heart Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dongtan Sacred Heart Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study compares the application of a picosecond 1064-nm laser with a diffractive lens
      array with nonablative fractional laser for the treatment of acne scarring.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This trial is a 17-week, prospective, randomized split-face study that compares the results
      between two facial sides either receiving the picosecond 1064-nm laser or nonablative
      fractional laser treatment for atrophic acne scar.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2019</start_date>
  <completion_date type="Anticipated">April 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Split-face comparison study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in the mean of the ECCA grading scale</measure>
    <time_frame>Week 17</time_frame>
    <description>The ECCA (échelle d'évaluation clinique des cicatrices d'acné) grading scale: minimum score 0; maximum score 270; higher values represent a worse outcome.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Acne Scars</condition>
  <arm_group>
    <arm_group_label>Picosecond laser</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention: four consecutive sessions of 1,064-nm picosecond laser at 3-week intervals</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fractional laser</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intervention: four consecutive sessions of nonablative fractional laser at 3-week intervals</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laser therapy</intervention_name>
    <description>4 consecutive sessions of laser therapy</description>
    <arm_group_label>Fractional laser</arm_group_label>
    <arm_group_label>Picosecond laser</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects with facial atrophic acne scars

          -  Subjects who observe the schedules and protocols of the clinical trial

          -  Subjects who give informed consent to participate in the clinical trial

        Exclusion Criteria:

          -  Subjects who have active acne under treatment

          -  Subjects who had received any other treatments for acne scarring for 6 months prior to
             the first treatment

          -  Subjects who underwent other treatments including chemical, mechanical or laser
             resurfacing during the study period

          -  Subjects who have current acute illness

          -  Subjects who are considered inappropriate for the clinical trial under the judgement
             of investigators
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gyeong-Hun Park, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dongtan Sacred Heart Hospital, Hallym University College of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gyeong-Hun Park, MD, PhD</last_name>
    <phone>+82-31-8086-2839</phone>
    <email>parkgh@hallym.or.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Dongtan Sacred Heart Hospital, Hallym Universtiy College of Medicine</name>
      <address>
        <city>Hwaseong-si</city>
        <state>Gyeonggi-do</state>
        <zip>18450</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gyeong-Hun Park, MD, PhD</last_name>
      <phone>+82-31-8086-2839</phone>
      <email>parkgh@hallym.or.kr</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>February 20, 2019</study_first_submitted>
  <study_first_submitted_qc>February 21, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 22, 2019</study_first_posted>
  <last_update_submitted>April 30, 2019</last_update_submitted>
  <last_update_submitted_qc>April 30, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 2, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Dongtan Sacred Heart Hospital</investigator_affiliation>
    <investigator_full_name>Gyeong-Hun Park</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acne Vulgaris</mesh_term>
    <mesh_term>Cicatrix</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

